Why the study?
NPR1 and NPR2 have critical functions in signaling pathways, but much remains unknown about their localization and function in vivo.
The development of HA-tagged and phosphomimetic NPR1 and NPR2 mouse models provides a valuable tool for investigating the in vivo localization and phosphorylation-dependent regulation of natriuretic peptide receptors.
These mouse models warrant no clinical practice change; extends tools to probe NPR1/2 phosphorylation in heart and other organs.
The natriuretic peptide receptors NPR1 and NPR2, also known as guanylyl cyclase A and guanylyl cyclase B, have critical functions in many signaling pathways, but much remains unknown about their localization and function in vivo. To facilitate studies of these proteins, we developed genetically modified mouse lines in which endogenous NPR1 and NPR2 were tagged with the HA epitope. To investigate the role of phosphorylation in regulating NPR1 and NPR2 guanylyl cyclase activity, we developed mouse lines in which regulatory serines and threonines were substituted with glutamates, to mimic the negative charge of the phosphorylated forms (NPR1-8E and NPR2-7E). Here we describe the generation and applications of these mice. We show that the HA-NPR1 and HA-NPR2 mice can be used to characterize the relative expression levels of these proteins in different tissues. We describe studies using the NPR2-7E mice that indicate that dephosphorylation of NPR2 transduces signaling pathways in ovary and bone, and studies using the NPR1-8E mice that indicate that the phosphorylation state of NPR1 is a regulator of heart, testis, and adrenal function.
No takes yet. Share an insight, caveat, or question.
Egbert et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: